OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
The role of innate immune genes in Alzheimer's disease	93
Mechanisms underlying progression in multiple sclerosis	88
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management	84
Where are we moving in the classification of idiopathic inflammatory myopathies?	66
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?	62
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease	55
Tremor pathophysiology: lessons from neuroimaging	47
Amyotrophic lateral sclerosis: update on clinical management	46
What has been the impact of new drug treatments on epilepsy?	46
MRI findings as markers of idiopathic intracranial hypertension	45
Cognitive and behavioural impairment in amyotrophic lateral sclerosis	45
The state of telemedicine for persons with Parkinson's disease	44
Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases	44
Linking mechanisms of periodontitis to Alzheimer's disease	42
Serious video games and virtual reality for prevention and neurorehabilitation of cognitive decline because of aging and neurodegeneration	42
What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia	39
Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies	38
Acute bacterial meningitis	37
Update on neuroimaging in disorders of consciousness	36
Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus	36
Motion sickness: current concepts and management	35
Wilson disease	35
Chance and risk in epilepsy	33
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies	33
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	33

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics	32
Epilepsy, antiepileptic drugs and dementia	31
Localizing the epileptogenic zone	30
What are the epileptic encephalopathies?	29
E-health and multiple sclerosis	28
Dravet syndrome	27
Machine learning for classification and prediction of brain diseases: recent advances and upcoming challenges	27
The window of opportunity for treatment of progressive multiple sclerosis	27
The elusive promise of myostatin inhibition for muscular dystrophy	27
Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes	26
Update on genetics of amyotrophic lateral sclerosis	26
Advances in the treatment of neuropathic pain	26
MRI of neurodegeneration with brain iron accumulation	26
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis	24
Frontotemporal dementias: main syndromes and underlying brain changes	23
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs	23
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	22
MRI in disorders of consciousness	22
Neuralgic amyotrophy	22
Advances in physical rehabilitation of multiple sclerosis	21
Therapeutic strategies for Huntington's disease	20
Biomarkers in amyotrophic lateral sclerosis: a review of new developments	20
Prediction of motor recovery after stroke: being pragmatic or innovative?	20
Update on T cells in the virally infected brain: friends and foes	20
Overview of tau PET molecular imaging	19
Functional MRI in migraine	19
Interictal autonomic dysfunction	19
Stroke epidemiology and COVID-19 pandemic	19
The biological basis of chronic fatigue: neuroinflammation and innate immunity	19
Use of disease-modifying drugs during pregnancy and breastfeeding	18
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities	18
Rehabilitation of cortically induced visual field loss	18
Anti-gamma-aminobutyric acid receptor type A encephalitis: a review	18
The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases	17
Current trends in the clinical trial landscape for amyotrophic lateral sclerosis	17
Microglia in multiple sclerosis – pathogenesis and imaging	17
Vestibular and auditory manifestations of migraine	16
Neuromuscular complications of coronavirus disease-19	16
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis	16
What have we learned from cognition in the oldest-old	16
Lesion network mapping for symptom localization: recent developments and future directions	16
Management of autoimmune encephalitis	16
Reproducibility and replicability in neuroimaging data analysis	16
Central nervous system tuberculosis	15
The recent surge of functional movement disorders: social distress or greater awareness?	15
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis	15
Current concepts in acute vestibular syndrome and video-oculography	15
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?	15
New drugs for multiple sclerosis: new treatment algorithms	15
Data science in neurodegenerative disease: its capabilities, limitations, and perspectives	15

Learning from the comorbidities of epilepsy	14
Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and long term follow-up	14
Neuropathogenesis of acute coronavirus disease 2019	14
Insular seizures and epilepsies: Ictal semiology and minimal invasive surgery	14
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	14
MR imaging and spectroscopy in degenerative ataxias: toward multimodal, multisite, multistage monitoring of neurodegeneration	13
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years	13
Intravenous thrombolysis for acute ischemic stroke: why not?	13
Unveiling the neuroimaging-genetic intersections in the human brain	13
The cognitive costs, contraindications and complications of epilepsy surgery in adults	13
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment	13
Autoimmune nodopathies, an emerging diagnostic category	13
Methods of visual assessment in children with cortical visual impairment	13
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	12
Advances in the genetic classification of amyotrophic lateral sclerosis	12
Vestibular-autonomic interactions: beyond orthostatic dizziness	12
Novel pathophysiological insights in autoimmune myasthenia gravis	12
Updates on ophthalmic imaging features of optic disc drusen, papilledema, and optic disc edema	12
A reappraisal of injuries and accidents in people with epilepsy	12
Persistent inflammatory states and their implications in brain disease	12
Update on the management of status epilepticus	12
Triggers of migraine: where do we stand?	12
Immunotherapy in autoimmune encephalitis	12
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations	12
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	12
Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia	12
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	11
Influence of sex hormones on vestibular disorders	11
Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile	11
Targets for migraine treatment: beyond calcitonin gene-related peptide	11
Recent therapeutic prospects for Machado–Joseph disease	11
Advanced neuroimaging techniques in epilepsy	11
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	11
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?	11
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes	11
The role of telemedicine in acute stroke treatment in times of pandemic	11
Bilateral vestibulopathy: the causes, diagnosis, and treatments	11
Sudden unexpected death in epilepsy	11
Posttraumatic headache: recent progress	11
Novel approaches to prediction in severe brain injury	11
Hereditary transthyretin amyloidosis: current treatment	11
Long COVID and especially headache syndromes	11
Contribution of PET-MRI in brain diseases in clinical practice	11